- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
cGAS Antibody / Cytosolic DNA Sensor Antibody recognizes cyclic GMP-AMP synthase (cGAS), a key innate immune receptor that detects double-stranded DNA within the cytoplasm and initiates antiviral and inflammatory signaling. Under normal physiological conditions, DNA is confined to the nucleus and mitochondria, making the presence of cytosolic DNA an important indicator of viral infection, bacterial invasion, cellular stress, or genomic instability. Upon binding cytoplasmic DNA, cGAS catalyzes the synthesis of cyclic GMP-AMP (cGAMP), a second messenger that activates the STING signaling pathway and induces production of type I interferons and other inflammatory cytokines. Consequently, cGAS Antibody / Cytosolic DNA Sensor Antibody is widely used to investigate innate immunity, host defense, inflammation, and cancer biology.
Activation of the cGAS-STING pathway serves as one of the body's principal mechanisms for detecting pathogenic DNA and damaged self-DNA. Following activation, cGAMP binds to STING on the endoplasmic reticulum membrane, triggering signaling cascades involving TBK1 and IRF3 that culminate in transcription of interferon-stimulated genes and pro-inflammatory mediators. Beyond antiviral immunity, cGAS contributes to immune surveillance of tumor cells, regulation of cellular senescence, responses to DNA damage, and maintenance of genomic integrity. Tight regulation of cGAS activity is therefore essential for balancing effective immune protection while limiting inappropriate inflammatory responses.
Dysregulated cGAS signaling has been implicated in numerous diseases, including autoimmune disorders, chronic inflammatory diseases, viral infections, neurodegenerative conditions, and multiple cancers. Excessive activation by self-DNA contributes to autoinflammatory syndromes and tissue injury, whereas impaired cGAS function can reduce antiviral immunity and weaken antitumor immune responses. Because pharmacologic modulation of the cGAS-STING pathway has become an active area of therapeutic development, cGAS has emerged as an important biomarker in immunology, oncology, infectious disease, and translational research.
NSJ Bioreagents' cGAS Antibody / Cytosolic DNA Sensor Antibody supports investigations into innate immune signaling, cytosolic DNA sensing, STING pathway activation, antiviral defense, inflammatory responses, cancer immunology, and DNA damage signaling. Reliable detection of cGAS enables researchers to study one of the central regulators of innate immune recognition and interferon-mediated host defense.
Explore additional antibodies involved in innate immunity, cytosolic DNA sensing, and antiviral host defense on our Immunology Antibodies page.
Optimal dilution of the cGAS Antibody / Cytosolic DNA Sensor Antibody should be determined by the researcher.
A synthetic partial protein derived from human cGAMP Synthase protein (amino acids A352-F504) was used as the immunogen for the cGAS Antibody.
cGAS Antibody is stable at -20oC for one year from date of receipt. After reconstitution, at 4oC for one month. It can also be aliquoted and stored frozen at -20oC for six months. Avoid repeated freeze-thaw cycles.
cGAS antibody, CGAS antibody, Cyclic GMP-AMP Synthase antibody, Cytosolic DNA Sensor antibody, MB21D1 antibody, cGAMP Synthase antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.